Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 207,645 | 198,066 | 196,417 | 229,260 | 192,511 |
| Cost of Goods | 172,027 | 156,157 | 142,333 | 148,976 | 132,032 |
| Gross Profit | 35,618 | 41,909 | 54,084 | 80,284 | 60,479 |
| Operating Expenses | 71,777 | 114,061 | 76,145 | 55,299 | 49,160 |
| Operating Income | -36,132 | -71,995 | -21,728 | 25,961 | 11,351 |
| Interest Expense | 714 | 292 | 377 | 493 | 853 |
| Other Income | 208 | -555 | 53 | 2,422 | 3,887 |
| Pre-tax Income | -36,638 | -72,842 | -22,052 | 27,890 | 14,385 |
| Income Tax | -4,342 | -9,971 | -5,357 | 7,330 | 5,449 |
| Net Income Continuous | -32,296 | -62,871 | -16,695 | 20,560 | 8,936 |
| Net Income | $-32,296 | $-62,871 | $-16,695 | $20,560 | $8,936 |
| EPS Basic Total Ops | -1.08 | -2.05 | -0.54 | 0.66 | 0.28 |
| EPS Basic Continuous Ops | -1.08 | -2.05 | -0.54 | 0.66 | 0.28 |
| EPS Diluted Total Ops | -1.08 | -2.05 | -0.54 | 0.65 | 0.27 |
| EPS Diluted Continuous Ops | -1.08 | -2.05 | -0.54 | 0.65 | 0.27 |
| EPS Diluted Before Non-Recurring Items | -0.42 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,350 | $-17,690 | $18,301 | $43,983 | $28,341 |